Dr. Hasselberg posted on LinkedIn Aug. 10 saying that he’s seeing health systems take two different approaches to generative AI adoption. The first is banning the technology altogether.
“Some have elected to ban the use of it until there is better guidance from the regulators (i.e. ONC, FDA) and/or are electing to wait until their electronic health record vendor offers the AI solution,” he wrote.
The second approach he sees health systems taking is one in which they are fully embracing it or creating their own internal tools in-house.
But, according to Dr. Hasselberg, building tools in-house doesn’t always mean they will be cost effective.
“In my opinion, it has never been easier or [more] cost effective for health systems to build their own solutions to solve our own problems,” he wrote.
Dr. Hasselberg was replying to a recent survey from Bain & Co. that found that only 6 percent of health system executives have a generative AI strategy for their organization.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
